GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yunnan Biovalley Pharmaceutical Co Ltd (BJSE:833266) » Definitions » Policy Acquisition Expense

Yunnan Biovalley Pharmaceutical Co (BJSE:833266) Policy Acquisition Expense


View and export this data going back to 2020. Start your Free Trial

What is Yunnan Biovalley Pharmaceutical Co Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Yunnan Biovalley Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 999 Biological Valley Street, Majinpu New District, High-tech Zone, Yunnan Province, Kunming City, CHN, 650500
Yunnan Biovalley Pharmaceutical Co Ltd engages in research and development, production, and marketing of pharmaceuticals and health care based on herbal medicines. The products on the market include breviscapine injection, breviscapine Shengmai capsules, breviscapine tablets, breviscapine dripping pills, Erigeron Capsules, Erigeron Soft Capsules.